CAMBRIDGE, Mass.--(BUSINESS WIRE)--Helicos BioSciences, a pioneer in high-speed, high-sensitivity sequencing, today announced that it has received a $2 Million grant from the National Human Genome Research Institute (NHGRI) as part of the Institute’s “Revolutionary Genome Sequencing Technologies – The $1000 Genome” research program. The grant will fund research of Helicos’ proprietary single molecule sequencing technology (tSMS™) for ultra low cost resequencing applications and de novo sequencing of large genomes. The funds will accelerate Helicos’ efforts to revolutionize medicine by enabling the sequencing and characterization of genomes across thousands of samples.
